Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Goodwill & Intangibles (2020 - 2025)

10x Genomics' Goodwill & Intangibles history spans 6 years, with the latest figure at $4.5 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 77.65% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $4.5 million, down 77.65%, while the annual FY2025 figure was $4.5 million, 77.65% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $4.5 million at 10x Genomics, down from $69.3 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $69.3 million in Q3 2025 and bottomed at $4.5 million in Q4 2025.
  • The 5-year median for Goodwill & Intangibles is $26.3 million (2023), against an average of $24.9 million.
  • The largest annual shift saw Goodwill & Intangibles tumbled 82.79% in 2023 before it soared 328.4% in 2024.
  • A 5-year view of Goodwill & Intangibles shows it stood at $29.9 million in 2021, then dropped by 8.49% to $27.4 million in 2022, then crashed by 82.79% to $4.7 million in 2023, then skyrocketed by 328.4% to $20.2 million in 2024, then tumbled by 77.65% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for TXG's Goodwill & Intangibles are $4.5 million (Q4 2025), $69.3 million (Q3 2025), and $19.2 million (Q2 2025).